Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Endoscopic Submucosal Dissection (ESD) and Endoscopic Mucosal Band Ligation (EMBL) for Early Cancer
- Conditions
- Early Cancer
- Interventions
- Procedure: endoscopic submucosal dissection (ESD) and endoscopic mucosal band ligation (EMBL) for early cancer
- First Posted Date
- 2016-11-02
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT02952794
- Locations
- 🇨🇳
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients
Phase 3
- Conditions
- Colorectal Carcinoma
- Interventions
- First Posted Date
- 2016-10-17
- Last Posted Date
- 2016-10-17
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 164
- Registration Number
- NCT02935764
Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma
Phase 2
Completed
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2016-09-27
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 70
- Registration Number
- NCT02916511
- Locations
- 🇨🇳
Fudan Universtiy Shanghai Cancer Center, Shanghai, Shanghai, China
Fulvestrant 500mg in Patients With Advanced Breast Cancer
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 500
- Registration Number
- NCT02909361
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
Transanual Tube Placement in Low Anterior Resection (LAR) for Rectal Cancer
Phase 2
- Conditions
- Rectal Cancer
- Interventions
- Device: transanual tube placement
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2016-09-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 520
- Registration Number
- NCT02905968
- Locations
- 🇨🇳
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
The Maintenance Treatment of UFT in Advanced Gastric Cancer
- First Posted Date
- 2016-09-16
- Last Posted Date
- 2016-10-12
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 58
- Registration Number
- NCT02903498
Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer
Not Applicable
- Conditions
- Rectal Carcinoma
- Interventions
- Procedure: Robot-assisted resectionProcedure: Laparoscopic resection
- First Posted Date
- 2016-06-29
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1240
- Registration Number
- NCT02817126
- Locations
- 🇨🇳
Chinese PLA General Hospital of Northern Theatre Command (former Shenyang Military General Hospital), Shenyang, Liaoning, China
🇨🇳The Southwest Hospital of Army Medical University, Chongqing, Chongqing, China
🇨🇳The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma
Phase 3
- Conditions
- Malignant Neoplasm Other Gallbladder/Extrahepatic Bile Duct
- Interventions
- First Posted Date
- 2016-06-14
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 140
- Registration Number
- NCT02798510
- Locations
- 🇨🇳
Fudan university cancer hospital, Shanghai, Shanghai, China
The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites
Phase 2
- Conditions
- Stomach NeoplasmsPeritoneal Metastasis
- Interventions
- First Posted Date
- 2016-05-20
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT02779608
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer
Phase 2
- Conditions
- Colonic Neoplasms
- Interventions
- Drug: XELOX or FOLFOX chemotherapy
- First Posted Date
- 2016-05-19
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1960
- Registration Number
- NCT02777437
© Copyright 2025. All Rights Reserved by MedPath